Teva Pharmaceutical Industries Ltd. announced the launch of the Authorized Generic of Detrol(R) LA (tolterodine tartrate extended-release capsules) 2 mg and 4 mg in the U.S. market.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.1 USD | +0.71% | +1.66% | +63.79% |
01/07 | Sector Update: Health Care Stocks Retreat Late Afternoon | MT |
01/07 | Sector Update: Health Care Stocks Slipping in Afternoon Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.79% | 19.37B | |
+60.25% | 841B | |
+38.89% | 625B | |
-4.49% | 360B | |
+18.30% | 327B | |
+9.64% | 300B | |
+15.42% | 242B | |
+3.56% | 228B | |
+18.02% | 227B | |
+12.87% | 174B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Announces Launch of Authorized Generic of Detrol(R)